MST, headquartered in Redmond, Wash., designs, manufactures and markets ophthalmic surgical products, focusing on single-use devices used in cataract surgery.
“The acquisition of MST continues our strategy of focusing on critical products in niche markets with strong growth drivers, expanding our surgical product offering in ophthalmology,” said Andrew Williams, Halma’s chief executive, in the release. “The international presence of our other ophthalmic product businesses offers exciting growth opportunities for MST under Halma’s ownership.”
Halma, a safety, health and environmental technology group, is headquartered in the United Kingdom.
Related Articles on Ophthalmology:
Alabama’s Trussville VisionFirst Eye Center Begins Offering Laser Cataract Surgery
Study: Vision Insurance Should Be Mandatory in Health Plans
25 Statistics on Ophthalmology Charges & Revenue in Surgery Centers
